|
|
 |
|
Viewing report
|
|
|
|
Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential
Datamonitor, Dec 2007, Pages: 139
Endometriosis is a painful, menstrual-related disorder that is thought to affect approximately 10% of the female population of reproductive age. Despite this large patient potential, growth of the endometriosis market has been limited by low levels of investment, poor awareness among physicians and the public, problematic diagnosis, and lack of effective therapies.
Scope
- Review of treatments and players in the seven major markets including their strategies for success.
- Movement of patients, depending on their treatment goal, through the referral and the treatment pathway.
- Overview of the pipeline including coverage of each of the novel mechanisms of action currently being explored.
- Identification of the unmet need, supported by international opinion leader insight.
Highlights of this title
Supporting celebrity spokespeople is a useful strategy for pharmaceutical companies to adopt in the endometriosis market in order to destigmatize the disease and expand the patient population, as witnessed in the erectile dysfunction and osteoporosis markets.
Imaging techniques, in particular ultrasonography, have the potential to become the new gold-standard diagnostic procedure. Biomolecular and genetic diagnostic tests, to replace CA-125, would be well received by physicians and several are being trialed currently.
In the current litigious climate and given the return on investment based on the potential patient population, opinion leaders advise that manufacturers of new products would be justified in pursuing a specific endometriosis label.
Key reasons to purchase this title
- Quantify the number of reproductively aged women with endometriosis in the general population and in gynecologic populations in the US, 5EU, and Japan
- Understand opinion leaders views on topical issues and unmet need in the endometriosis market.
- Assess the competitive environment upon launch of a product based on the analysis of key pipeline products and R&D strategies.
Customers who bought this item also bought
Analysis of Boston Scientific
Analysis of Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. Strategic Analysis Profile
Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential
MedTox Scientific, Inc. Company Profile
Cardiovascular Devices Pipeline Analysis: Innovation and Consolidation Intensify Competition February 22
Scientific Games Corporation - Company Analysis
Boston Scientific Medical Device Company Intelligence Report
|
|
|
|
